Klona Biotech
Unlocking 3D Printing for Mechanically Demanding Human Tissues
At Klona Biotech, we're reimagining the future of bioprinting.
Our team is developing cutting-edge composite extrusion technologies that combine the precision of high-resolution 3D printing with the strength of fibrous, scaffold-based materials.
The result? Biocompatible structures that are not only biologically friendly but also mechanically robust, a breakthrough for demanding tissue applications.
We're building tools for researchers and clinicians in tissue engineering, regenerative medicine, and next-generation implant design. Our systems are made to maintain cell viability while providing structural strength, addressing one of the biggest challenges in soft biomaterials today.
Our goal is to make this technology as common in hospitals as MRI machines. We envision a world where strong, safe, and reliable patient-specific organs can be printed on demand.
As we grow, we will partner with research hospitals and clinical teams to accelerate real-world testing and navigate the regulatory landscape from day one.
Dylan Yeo
Co-Founder & CEO
Born to a family of entrepreneurs, Dylan is determined to continue a family legacy of successful buisness and social good. Currently an MD PhD at the University of Oxford specialising in Musculoskeletal Tissue Engineering, he is fully funded by the Kennedy Trust's OxKen Studentship. He has NZ Scholarships in Biology, Physics, and History, and has leadership experience as a sergeant in Singapore's elite Intelligence Recon formation. He co-founded the Oxford Biohacking Society, helping it grow to its current 500+ members; is a Foresight Institute longevity grantee, and is part of the first UK cohort of Fifty Years' 5050 program.
Thomas Groom
Co-Founder & CTO
Thomas is an aspiring founder with an MSc in Human and Biological Robotics from Imperial College. A Laidlaw and Arkwright Scholar, as well as a winner of the prestigious IET Prize for academic excellence, he has been repeatedly distinguished for both leadership and technical expertise. He has hands-on experience in rapid prototyping and product development while working at Rolls-Royce Motor Cars. Driven by a desire to develop transformative medical technologies, Thomas stepped away from a PhD at Imperial to pursue his startup full-time and make a real-world impact.
For inquiries, please email us at Partner@KlonaBiotech.com or fill out the form below